By Andrea Anderson

WASHINGTON, DC (GenomeWeb News) – At the American Association for Cancer Research annual meeting here this week, the directors of both the National Institutes of Health and the National Cancer Institute highlighted the importance of transforming basic cancer research into improved patient care.

During his talk on exceptional opportunities for cancer research, National Institutes of Health Director Francis Collins described some national programs and strategies for bolstering such translational research.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.